We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $60.8B
1-Year Est. Return 42.06%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
AUM
$49.3B
AUM Growth
+$3.1B
Cap. Flow
-$516M
Cap. Flow %
-1.05%
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$78.5M
2
NVDA icon
NVIDIA
NVDA
+$75.6M
3
LLY icon
Eli Lilly
LLY
+$70.2M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$58.7M
5
META icon
Meta Platforms (Facebook)
META
+$55.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$107M
2
PFE icon
Pfizer
PFE
+$70M
3
JNJ icon
Johnson & Johnson
JNJ
+$68M
4
DHR icon
Danaher
DHR
+$56.4M
5
WMT icon
Walmart Inc
WMT
+$54.2M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Healthcare 17.5%
3 Financials 11.6%
4 Consumer Discretionary 9.63%
5 Industrials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIPS icon
1501
Vipshop
VIPS
$6.28B
$699K ﹤0.01%
42,350
+350
+0.8% +$5.48K
IMKTA icon
1502
Ingles Markets
IMKTA
$1.58B
$698K ﹤0.01%
8,440
FRME icon
1503
First Merchants
FRME
$2.64B
$698K ﹤0.01%
24,710
+5,400
+28% +$153K
SFBS
1504
ServisFirst Bancshares
SFBS
$4.72B
$697K ﹤0.01%
34,090
+600
+2% +$13.9K
BANR icon
1505
Banner Corp
BANR
$2.61B
$696K ﹤0.01%
15,946
PGRE
1506
DELISTED
Paramount Group
PGRE
$694K ﹤0.01%
156,590
GMAB icon
1507
Genmab
GMAB
$20.7B
$692K ﹤0.01%
18,200
MRTX
1508
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$692K ﹤0.01%
19,140
+3,150
+20% +$130K
ANIP icon
1509
ANI Pharmaceuticals
ANIP
$1.64B
$691K ﹤0.01%
12,833
+800
+7% +$35.5K
INVX
1510
Innovex International
INVX
$2.1B
$687K ﹤0.01%
29,513
PHR icon
1511
Phreesia
PHR
$679M
$687K ﹤0.01%
22,140
+1,500
+7% +$47K
PI icon
1512
Impinj
PI
$5.27B
$686K ﹤0.01%
7,650
+500
+7% +$53.3K
INDB icon
1513
Independent Bank
INDB
$3.97B
$685K ﹤0.01%
15,401
AGYS icon
1514
Agilysys
AGYS
$3.14B
$683K ﹤0.01%
9,950
BOKF icon
1515
BOK Financial
BOKF
$8.31B
$683K ﹤0.01%
8,450
ESTA icon
1516
Establishment Labs
ESTA
$2.21B
$682K ﹤0.01%
9,940
BWIN
1517
Baldwin Insurance Group
BWIN
$2.99B
$681K ﹤0.01%
27,470
AROC icon
1518
Archrock
AROC
$5.73B
$680K ﹤0.01%
66,370
+20,350
+44% +$201K
MRCY icon
1519
Mercury Systems
MRCY
$4.96B
$680K ﹤0.01%
19,661
CPRX
1520
DELISTED
Catalyst Pharmaceutical
CPRX
$680K ﹤0.01%
50,590
NBTB icon
1521
NBT Bancorp
NBTB
$2.72B
$678K ﹤0.01%
21,280
+500
+2% +$16.7K
KKR icon
1522
KKR & Co
KKR
$96.7B
$678K ﹤0.01%
12,100
OFG icon
1523
OFG Bancorp
OFG
$2.25B
$676K ﹤0.01%
25,909
BRC icon
1524
Brady Corp
BRC
$4.23B
$676K ﹤0.01%
14,203
ASTE icon
1525
Astec Industries
ASTE
$1.02B
$672K ﹤0.01%
14,779
+450
+3% +$18.6K

Similar funds

Ensign Peak Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
  • Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
  • Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
  • Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
  • Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.